Actually Esceram is the most undervalued glove stock at the moment.
The PE using latest Qr is only around 12 and there is 40%++ growth in production capacity for this year. Furthermore molding costs only a very low portion in gloves manufacturing, there will be a huge room in increase in margin since all the gloves manufacturer is expanding their production lines. The price should be around 1.1-1.5 if you compare it to other stocks like HLT,flexi, etc.

only 18m was disposed please, another notice is due to deemed interest by virtue of Section 59 of the Companies Act 2016....anyway it is still interesting...

ES was 'detached' from glove stocks was due to declining ASP of gloves might not affect its business, gloves companies still need to purchase moulding from ES.

However, if the covid pandemic will last longer than anticipated, then it is still a positive signal to ES.

This is also the reason I decided to hold it for the long term.

Aside from good profit for this QR, please take a look at the other & trade payables of the company.
QR1 = 4.1m, QR2 = 18.5m, this QR2 = 29.8m, i believe the main reason is due to their customers are willing to pay in advance to secure their orders, which means sales of the company is secured in the coming QRs.

okay, this stock is going to limit up monday...lucky i avg up afternoon

it seems like 0.8 block will be destroyed in one shot....

Actually this stock is undervalued since glove stock are out of investors' radar, people will realize its value after another 2-3 qr results....

fair price is around 0.7-0.8 now, but after qe might be 0.9-1.5

why always got ppl ask to open interstate travel on 18.2? As a supporter of Genm, i prefer not to lift the restriction in the coming weeks, don't just look for the short term profit.
Lift the travel ban may lead to rising in cases, only vaccine is not enough to end the pandemic.

@jasonred79
Div from TG must go into someone pocket, either A or B.
If go into A, then why B need to pay A again?
If go into B, then B pay back to A, the money at the end is from TG.

correct me if i am wrong.

actually the price is still relatively very low if you believe we're going to beat the covid19 in the coming months....
50% to go to RM6-7, and 50% to go to RM4, which one u choose, the answer is clear here

1H20: -116m
3Q20: 54m
4Q20: 131m
---------------
Total: 69m
---------------
Bear in mind that 4Q20's result 131m was during the peak of covid pandemic, the capacity was not fully utilized due to SOPs and restrictions.

If post-covid PBT were increased by 30%, it will be 131m x 130% = 170.3m
170.3m x 4Q = 681m

Pre-covid result: 1H19: 373mil 2H19: 315mil = 688m

This is just a simple calculation for reference, just bear in mind only an increment of 30% is taken into calculation for pre-covid result.